oral LBH589
Showing 1 - 25 of >10,000
NSCLC, Mesothelioma Trial in Canada, United States (LBH589)
Completed
- Carcinoma, Non-Small-Cell Lung
- Mesothelioma
-
Fayetteville, Arkansas
- +4 more
Dec 16, 2020
Chronic Myeloid Leukemia in Chronic Phase Trial in Belgium, Germany (LBH589)
Terminated
- Chronic Myeloid Leukemia in Chronic Phase
-
Bruxelles, Belgium
- +9 more
Jul 14, 2021
Cutaneous T-Cell Lymphoma Trial in United States (Panobinostat)
Terminated
- Cutaneous T-Cell Lymphoma
-
Birmingham, Alabama
- +17 more
Aug 16, 2021
HER-2 Positive Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (IV LBH589, Oral LBH589, trastuzumab)
Completed
- HER-2 Positive Breast Cancer
- Metastatic Breast Cancer
- IV LBH589
- +3 more
-
Mobile, Alabama
- +6 more
Dec 16, 2020
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester
Terminated
- Clear Cell Renal Cell Carcinoma
- +3 more
- panobinostat
- +7 more
-
Buffalo, New York
- +1 more
Aug 11, 2022
Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocytopenia Trial in United States (Panobinostat)
Terminated
- Primary Myelofibrosis
- +2 more
-
Scottsdale, Arizona
- +8 more
Jul 9, 2021
Melanoma, Skin Cancer Trial in Tampa (Panobinostat, Ipilimumab)
Completed
- Melanoma
- Skin Cancer
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 18, 2023
MDS (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML) Trial in Japan (Panobinostat)
Completed
- Myelodysplastic Syndromes (MDS)
- +2 more
-
Nagoya-city, Aichi, Japan
- +5 more
Dec 16, 2020
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +20 more
- panobinostat
- +6 more
-
Scottsdale, Arizona
- +1 more
May 6, 2022
Sickle Cell Disease Trial in Augusta (panobinostat)
Active, not recruiting
- Sickle Cell Disease
-
Augusta, GeorgiaAugusta University
May 26, 2021
MDS (MDS) Trial in United States (Panobinostat)
Terminated
- Myelodysplastic Syndromes (MDS)
-
Fort Myers, Florida
- +6 more
Nov 18, 2021
Hepatocellular Carcinoma Trial in Erlangen (Sorafenib + LBH589)
Terminated
- Hepatocellular Carcinoma
- Sorafenib + LBH589
-
Erlangen, GermanyDepartment of Medicine 1, University Hospital Erlangen
Dec 10, 2020
Advanced Solid Tumors Trial in Worldwide (panobinostat (LBH589))
Completed
- Advanced Solid Tumors
- panobinostat (LBH589)
-
Salt Lake City, Utah
- +4 more
Dec 16, 2020